Physician profile
Tricia Lynn Wright
NPI 1851388540
$12,219.22
in general payments reported to CMS, 2019-2025
59 companies · $1,399 in 2025
The $1,399 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,474 · 2020: $1,283 · 2021: $2,118 · 2022: $1,726 · 2023: $2,098 · 2024: $2,121 · 2025: $1,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,618.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,026.11 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $1,259.01 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $907.43 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $834.78 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $818.98 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $750.40 | 2019-2025 | Evenity, Otezla, Repatha |
| Pfizer INC. | $595.36 | 2019-2025 | |
| Glaxosmithkline, LLC. | $556.61 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $381.30 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $331.71 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
| Sanofi-Aventis U.S. LLC | $295.37 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.66 | 2019-2024 | Jardiance, Ofev |
| Takeda Pharmaceuticals U.S.A., INC. | $263.87 | 2019-2024 | Eohilia, Trintellix |
| Novartis Pharmaceuticals Corporation | $248.84 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $184.03 | 2019-2023 | Airduo Digihaler |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tricia Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.